Compare LIVN & CRGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LIVN | CRGY |
|---|---|---|
| Founded | 1987 | 1986 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3B | 3.8B |
| IPO Year | 2015 | 2022 |
| Metric | LIVN | CRGY |
|---|---|---|
| Price | $78.50 | $14.19 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 17 |
| Target Price | ★ $90.55 | $18.44 |
| AVG Volume (30 Days) | 517.2K | ★ 10.2M |
| Earning Date | 11-04-2026 | 11-02-2026 |
| Dividend Yield | N/A | ★ 3.49% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.33 | N/A |
| Revenue | N/A | ★ $3,579,782,000.00 |
| Revenue This Year | $9.65 | $41.93 |
| Revenue Next Year | $7.10 | $22.29 |
| P/E Ratio | ★ $35.01 | $99.08 |
| Revenue Growth | N/A | ★ 22.14 |
| 52 Week Low | $48.82 | $7.68 |
| 52 Week High | $85.76 | $15.47 |
| Indicator | LIVN | CRGY |
|---|---|---|
| Relative Strength Index (RSI) | 50.35 | 60.08 |
| Support Level | $74.69 | $12.42 |
| Resistance Level | $82.39 | $15.47 |
| Average True Range (ATR) | 2.20 | 0.48 |
| MACD | 0.26 | 0.08 |
| Stochastic Oscillator | 48.00 | 95.81 |
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives approximately half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.
Crescent Energy Co is an energy company committed to delivering value for shareholders through disciplined growth, acquisition ideas, and the consistent return of capital. Its long-life, balanced portfolio combines stable cash flows from low-decline production with deep, high-quality development inventory. The company operates in one reportable segment, which is the exploration and production of crude oil, natural gas, and NGLs.